Spatial and temporal parameters of gait disturbances in schizophrenic patients

Schizophrenia Research

Volumn 69, Issue 2-3, 2004, Pages 159-166

  Putzhammer, Albert ^a,b   Heindl, Bernhard ^a   Broll, Karin ^a   Pfeiff, Liane ^a   Perfahl, Maria ^a   Hajak, Göran ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Antipsychotic Agents; Gait; Hypokinesia; Movement; Parkinsonism; Schizophrenia

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE;

ARTICLE; CONTROLLED STUDY; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT; GAIT DISORDER; HUMAN; HYPOKINESIA; LOCOMOTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; WALKING SPEED;

ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; GAIT DISORDERS, NEUROLOGIC; HUMANS; LOCOMOTION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SPATIAL BEHAVIOR; TIME PERCEPTION; WALKING;

EID: 2642559428     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00090-2     Document Type: Article

References (50)

1. Bradshaw J., Mattingley J.B. Brain Anom. Schizophr. 1995;362-366
2. Braus D.F., Ende G., Weber-Fahr W., Sartorius A., Krier A., Hubrich-Ungureanu P., Ruf M., Stuck S., Henn F.A. Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients. Schizophr. Res. 39:1999;19-29
3. Braus D.F., Ende G., Hubrich-Ungureanu P., Henn F.A. Cortical response to motor stimulation in neuroleptic-naive first episode schizophrenics. Psychiatry Res. 98:2000;145-154
4. Brotchie P., Iansek R., Horne M.K. Motor function of the monkey globus pallidus: 1. Neuronal discharge and parameters of movement. Brain. 114:1991;1667-1683
5. Brotchie P., Iansek R., Horne M.K. Motor function of the monkey globus pallidus: 2. Cognitive aspects of movement and phasic neuronal activity. Brain. 114:1991;1685-1702
6. Chouinard G., Ross-Chouinard A., Annable L., Jones B.D. The extrapyramidal symptoms rating scale. Can. J. Neurol. Sci. 7:1980;233-244
7. Davis R.B. Reflections on clinical gait analysis. J. Electromyogr. Kinesiol. 7:1997;251-257
8. Deecke L. Planning, preparation, execution, and imagery of volitional action. Brain Res. Cogn. Brain Res. 3:1996;59-64
9. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285
10. Dietz V. Gait disorders. J. Neurol. Neurosurg. Psychiatry. 70:2001;288
11. Dietz V. Physiology of human gait. Neural processes. Adv. Neurol. 87:2001;53-63
12. DuChantier K., Molen N.H., Rozendal R.H. Step length, step frequency and temporal factors of the stride in normal human walking. Proc. K. Ned. Akad. Wet, Ser. C. 73:1970;214-227
13. Flyckt L., Sydow O., Bjerkenstedt L., Edman G., Rydin E., Wiesel F.A. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res. 86:1999;113-129
14. Gabell A., Nayak U.S. The effect of age on variability in gait. J. Gerontol. 39:1984;662-666
15. Grieve D.W., Gear R.J. The relationship between length of stride, step frequency, time of swing and speed of walking for children and adults. Ergonomics. 9:1966;379-399
16. Guenther W., Brodie J.D., Bartlett E.J., Dewey S.L., Henn F.A., Volkow N.D., Alper K., Wolkin A., Cancro R., Wolf A.P. Diminished cerebral metabolic response to motor stimulation in schizophrenics: a PET study. Eur. Arch. Psychiatry Clin. Neurosci. 244:1994;115-125
17. Gupta S., Andreasen N.C., Arndt S., Flaum M., Schultz S.K., Hubbard W.C., Smith M. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am. J. Psychiatry. 152:1995;191-196
18. Guy W. Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology. 1976;Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, Washington, DC
19. Hassin-Baer S., Sirota P., Korczyn A.D., Treves T.A., Epstein B., Shabtai H., Martin T., Litvinjuk Y., Giladi N. Clinical characteristics of neuroleptic-induced parkinsonism. J. Neural Transm. 108:2001;1299-1308
20. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 13:1987;261-276
21. Kennedy P.F., Hershon H.I., McGuire R.J. Extrapyramidal disorders after prolonged phenothiazine therapy. Br. J. Psychiatry. 118:1971;509-518
22. Kimura M., Aosaki T., Hu Y., Ishida A., Watanabe K. Activity of primate putamen neurons is selective to the mode of voluntary movement: visually guided, self-initiated or memory-guided. Exp. Brain Res. 89:1992;473-477
23. Korczyn A.D., Goldberg G.J. Extrapyramidal effects of neuroleptics. J. Neurol. Neurosurg. Psychiatry. 39:1976;866-869
24. Lemke M.R., Wendorff T., Mieth B., Buhl K., Linnemann M. Spatiotemporal gait patterns during over ground locomotion in major depression compared with healthy controls. J. Psychiatr. Res. 34:2000;277-283
25. Mattay V.S., Callicott J.H., Bertolino A., Santha A.K., Tallent K.A., Goldberg T.E., Frank J.A., Weinberger D.R. Abnormal functional lateralization of the sensorimotor cortex in patients with schizophrenia. NeuroReport. 8:1997;2977-2984
26. Morris M.E., Iansek R., Matyas T.A., Summers J.J. Ability to modulate walking cadence remains intact in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 57:1994;1532-1534
27. Morris M.E., Iansek R., Matyas T.A., Summers J.J. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain. 119(Pt. 2):1996;551-568
28. Müller J.L., Klein H.E. Neuroleptic therapy influences basal ganglia activation: a functional magnetic resonance imaging study comparing controls to haloperidol- and olanzapine-treated inpatients. Psychiatry Clin. Neurosci. 54:2000;653-658
29. Müller J.L., Roder C., Schuierer G., Klein H.E. Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study. Psychiatry Clin. Neurosci. 56:2002;77-84
30. Murray M.P., Kory R.C., Clarkson B.H., Sepic S.B. Comparison of free and fast speed walking patterns of normal men. Am. J. Phys. Med. 45:1966;8-23
31. Murray M.P., Kory R.C., Clarkson B.H. Walking patterns in healthy old men. J. Gerontol. 24:1969;169-178
32. Murray M.P., Kory R.C., Sepic S.B. Walking patterns of normal women. Arch. Phys. Med. Rehabil. 51:1970;637-650
33. Obens T., Becker N.L., Hirning P. "Akustische" Laufanalyse. Orthopädieschuhtechnik. 4:1996;34-39
34. Playford E.D., Jenkins I.H., Passingham R.E., Nutt J., Frackowiak R.S., Brooks D.J. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann. Neurol. 32:1992;151-161
35. Portscher M., Vogt L., Pfeifer K., Banzer W. Reproducibility of lumbar spine kinematics in clinical gait analysis. Sportverletz. Sportschaden. 14:2000;50-54
36. Putzhammer A., Müller J., Heindl B., Broll K., Pfeiff L., Perfahl M., Hess L., Koch H. Three dimensional ultrasonic gait analysis in schizophrenic patients. Psychiatr. Pr. 2003;. (in press)
37. Rascol O., Sabatini U., Chollet F., Celsis P., Montastruc J.L., Marc-Vergnes J.P., Rascol A. Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine. Arch. Neurol. 49:1992;144-148
38. Sanders R.D., Keshavan M.S., Schooler N.R. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am. J. Psychiatry. 151:1994;1231-1233
39. Saunders J.B., Inman V.T., Eberhardt H.D. The major determinants of normal and pathological gait. J. Bone Jt. Surg. 35A:1953;543-558
40. Sautter F.J., McDermott B.E., Cornwell J., Black F.W., Borges A., Johnson J., O'Neill P. Patterns of neuropsychological deficit in cases of schizophrenia spectrum disorder with and without a family history of psychosis. Psychiatry Res. 54:1994;37-49
41. Schroder J., Niethammer R., Geider F.J., Reitz C., Binkert M., Jauss M., Sauer H. Neurological soft signs in schizophrenia. Schizophr. Res. 6:1991;25-30
42. Schroder J., Wenz F., Schad L.R., Baudendistel K., Knopp M.V. Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. Br. J. Psychiatry. 167:1995;197-201
43. Spence S.A., Brooks D.J., Hirsch S.R., Liddle P.F., Meehan J., Grasby P.M. A PET study of voluntary movement in schizophrenic patients experiencing passivity phenomena (delusions of alien control). Brain. 120:1997;1997-2011
44. Schroder J., Essig M., Baudendistel K., Jahn T., Gerdsen I., Stockert A., Schad L.R., Knopp M.V. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage. 9:1999;81-87
45. Sloman L., Berridge M., Homatidis S., Duck T. Gait patterns of depressed patients and normal subjects. Am. J. Psychiatry. 139:1982;94-97
46. Stephen P.J., Williamson J. Drug-induced parkinsonism in the elderly. Lancet. 2:1984;1082-1083
47. Vogt L., Banzer W. Measurement of lumbar spine kinematics in incline treadmill walking. Gait Posture. 9:1999;18-23
48. Vogt L., Pfeifer K., Banzer W. Application of modern methods of movement analysis for functional diagnosis and risk screening of the athlete. Sportverletz. Sportschaden. 15:2001;M33-M36
49. Vogt L., Pfeifer K., Portscher A.M., Banzer W. Influences of nonspecific low back pain on three-dimensional lumbar spine kinematics in locomotion. Spine. 26:2001;1910-1919
50. Zebris Test Report, 1998. Ultrasonic measurement system for motor analysis CMS70P. Zebris Medical Systems, Tübingen, Germany/Department of Electrical, Machinery and Plant Engineering, EMC-Test-Center of the State Bavaria, Nuremberg, Germany.